Bioventix PLC

Equities

BVXP

GB00B4QVDF07

Biotechnology & Medical Research

Market Closed - London S.E. 11:35:15 2024-04-26 am EDT 5-day change 1st Jan Change
4,450 GBX +0.56% Intraday chart for Bioventix PLC -3.26% +3.49%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Bioventix ups dividend as profit rises; says headwinds temporary AN
Bioventix plc Announces Interim Dividend, Payable on 26 April 2024 CI
Bioventix PLC Reports Earnings Results for the Half Year Ended December 31, 2023 CI
Bioventix CEO Harrison sells GBP2.6 million in shares AN
Bioventix hails "technical progress" as profit rises AN
Earnings Flash (BVXP.L) BIOVENTIX Reports FY23 EPS GBX158.28 MT
Bioventix PLC Reports Earnings Results for the Full Year Ended June 30, 2023 CI
Bioventix PLC Announces Second Interim Dividend, Payable on 24 November 2023 CI
Bioventix plc Appoints Joanne (Jo) Pisani to the Board as an Independent Non-Executive Director CI
New Future CEO buys GBP800,000 in shares AN
EARNINGS UPDATES: Belvoir ups yearly payout; SigmaRoc swings to profit AN
Bioventix PLC Reports Earnings Results for the Half Year Ended December 31, 2022 CI
Bioventix PLC Reports Earnings Results for the Half Year Ended December 31, 2022 CI
Bioventix plc Announces an Interim Dividend, Payable on 21 April 2023 CI
BiVictriX's Anti-cancer Drug Shows Tolerability, Safety In Preclinical Study MT
UK shareholder meetings calendar - next 7 days AN
UK shareholder meetings calendar - next 7 days AN
UK shareholder meetings calendar - next 7 days AN
UK shareholder meetings calendar - next 7 days AN
UK shareholder meetings calendar - next 7 days AN
Bioventix annual profit up on sales versus heart-attack linked protein AN
Bioventix PLC Reports Earnings Results for the Full Year Ended June 30, 2022 CI
Bioventix PLC Announces Second Interim Dividend for the Year Ended 30 June 2022, Payable on 18 November 2022 CI
Bioventix PLC Has Announces Special Dividend, Payable on 18 November 2022 CI
UK earnings, trading statements calendar - next 7 days AN
Chart Bioventix PLC
More charts
Bioventix plc is a United Kingdom-based biotechnology company. The Company specializes in the development and commercial supply of high-affinity monoclonal antibodies with a primary focus on their application in clinical diagnostics, such as in automated immunoassays used in blood testing. It has created a sheep hybridoma technology to produce stable and productive cell lines that secrete sheep monoclonal antibodies (SMAs) of very high affinity. Its recombinant FAbs are modified to enable simple conjugation to enzymes (HRP, AP) or biotinylation or association as dimeric FAb2. It offers a portfolio of antibodies to customers for both commercial use and research and development purposes for the diagnosis or monitoring of a broad range of conditions, including heart disease, cancer, fertility, thyroid function, and drug abuse. It provides ELISA Kits to monitor human exposure to industrial pollutants. It supplies antibody products and services to clinical diagnostics companies.
Calendar
More about the company

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BVXP Stock
  4. News Bioventix PLC
  5. BiVictriX's Anti-cancer Drug Shows Tolerability, Safety In Preclinical Study